Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label PET study of dopamine transporter occupancy after repeated oral OPC-64005 in healthy males
jRCT2080222882Phase 1
- Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Start
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of OPC-64005, sponsored by Otsuka Pharmaceutical Co., Ltd. Primary endpoint: Dopamine transporter occupancy in the human brain.
02
Drugs
OPC-64005
Beyond the preview
Go deeper on jRCT2080222882.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222882.